Parametric approaches towards understanding the effects of the preferential D3 receptor agonist pramipexole on prepulse inhibition in rats

Pharmacology Biochemistry and Behavior

Volumn 95, Issue 4, 2010, Pages 473-478

  Chang, Wei li ^a   Swerdlow, Neal R ^a   Breier, Michelle R ^a   Thangaraj, Niveditha ^a   Weber, Martin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

D3 receptor; Dopamine; Pramipexole; Prepulse inhibition; Rats

Indexed keywords

DOPAMINE 3 RECEPTOR STIMULATING AGENT; PRAMIPEXOLE;

ADULT ANIMAL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; ESTRUS; FEMALE; MALE; MOTOR ACTIVITY; NEUROBIOLOGY; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; STARTLE REFLEX;

ACOUSTIC STIMULATION; ANIMALS; BENZOTHIAZOLES; DOPAMINE AGONISTS; ESTROUS CYCLE; FEMALE; MALE; MOTOR ACTIVITY; NEURAL INHIBITION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D3; SENSORY GATING; SEX CHARACTERISTICS; STARTLE REACTION; TIME FACTORS;

RATTUS;

EID: 77952543193     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.04.001     Document Type: Article

References (30)

1. Adams A.L., Hudson A., Ryan C.L., Doucette T.A. Effects of estrous stage and time of day on prepulse inhibition in female rats. J Neurosci Methods 2008, 173:295-298.
2. Braff D.L., Grillon C., Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 1992, 49:206-215.
3. Bubenikova V., Votava M., Horacek J., Palenicek T. Relation of sex and estrous phase to deficits in prepulse inhibition of the startle response induced by ecstasy (MDMA). Behav Pharmacol 2005, 16:127-130.
4. Campeau S., Davis M. Involvement of the central nucleus and basolateral complex of the amygdala in fear conditioning measured with fear-potentiated startle in rats trained concurrently with auditory and visual conditioned stimuli. J Neurosci 1995, 15:2301-2311.
5. Castellanos F.X., Fine E.J., Kaysen D., Marsh W.L., Rapoport J.L., Hallett M. Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results. Biol Psychiatry 1996, 39:33-41.
6. Conti L.H., Sutherland J.E., Muhlhauser C.M. Interaction between the effects of corticotropin-releasing factor and prepulse parameters on prepulse inhibition in two inbred rat strains and the F1 generation of a cross between them. Behav Brain Res 2009, 200:165-172.
7. Davis M. Apomorphine, d-amphetamine, strychnine and yohimbine do not alter prepulse inhibition of the acoustic startle reflex. Psychopharmacology 1988, 95:151-156.
8. Davis M., Mansbach R.S., Swerdlow N.R., Campeau S., Braff D.L., Geyer M.A. Apomorphine disrupts the inhibition of acoustic startle induced by weak prepulses in rats. Psychopharmacology 1990, 102:1-4.
9. Kinkead B., Yan F., Owens M.J., Nemeroff C.B. Endogenous neurotensin is involved in estrous cycle related alterations in prepulse inhibition of the acoustic startle reflex in female rats. Psychoneuroendocrinology 2008, 33:178-187.
10. Kinney G.G., Wilkinson L.O., Saywell K.L., Tricklebank M.D. Rat strain differences in the ability to disrupt sensorimotor gating are limited to the dopaminergic system, specific to prepulse inhibition, and unrelated to changes in startle amplitude or nucleus accumbens dopamine receptor sensitivity. J Neurosci 1999, 19:5644-5653.
11. Koch M. Sensorimotor gating changes across the estrous cycle in female rats. Physiol Behav 1998, 64:625-628.
12. Kumari V., Gray J.A., Gupta P., Luscher S., Sharma T. Sex differences in prepulse inhibition of the acoustic startle response. Pers Individ Dif 2003, 35:733-742.
13. Lehmann J., Pryce C.R., Feldon J. Sex differences in the acoustic startle response and prepulse inhibition in Wistar rats. Behav Brain Res 1999, 104:113-117.
14. Mansbach R.S., Geyer M.A., Braff D.L. Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology 1988, 94:507-514.
15. Marcondes F.K., Bianchi F.J., Tanno A.P. Determination of the estrous cycle phases of rats: some helpful considerations. Braz J Biol 2002, 62:609-614.
16. Millan M.J., Maiofiss L., Cussac D., Audinot V., Boutin J.A., Newman-Tancredi A. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes. J Pharmacol Exp Ther 2002, 303:791-804.
17. Palmer A.A., Dulawa S.C., Mottiwala A.A., Conti L.H., Geyer M.A., Printz M.P. Prepulse startle deficit in the Brown Norway rat: a potential genetic model. Behav Neurosci 2000, 114:374-388.
18. Piercey M.F., Walker E.L., Feldpausch D.L., Camacho-Ochoa M. High affinity binding for pramipexole, a dopamine D3 receptor ligand, in rat striatum. Neurosci Lett 1996, 219:138-140.
19. Svensson K., Carlsson A., Huff R.M., Kling-Petersen T., Waters N. Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors. Eur J Pharmacol 1994, 263:235-243.
20. Swerdlow N.R., Varty G.B., Geyer M.A. Discrepant findings of clozapine effects on prepulse inhibition of startle: is it the route or the rat?. Neuropsychopharmacology 1998, 18:50-56.
21. Swerdlow N.R., Geyer M.A., Hartman P.L., Sprock J., Auerbach P.P., Cadenhead K., et al. Sex differences in sensorimotor gating of the human startle reflex: all smoke?. Psychopharmacology 1999, 146:228-232.
22. Swerdlow N.R., Karban B., Ploum Y., Sharp R., Geyer M.A., Eastvold A. Tactile prepuff inhibition of startle in children with Tourette's syndrome: in search of an "fMRI-friendly" startle paradigm. Biol Psychiatry 2001, 50:578-585.
23. Swerdlow N.R., Shoemaker J.M., Auerbach P.P., Pitcher L., Goins J., Platten A. Heritable differences in the dopaminergic regulation of sensorimotor gating. II. Temporal, pharmacologic and generational analyses of apomorphine effects on prepulse inhibition. Psychopharmacology 2004, 174:452-462.
24. Swerdlow N.R., Breier M., Mora A.B., Ko D., Shoemaker J.M. A novel rat strain with enhanced sensitivity to the effects of dopamine agonists on startle gating. Pharmacol Biochem Behav 2008, 88:280-290.
25. Swerdlow N.R., Weber M., Qu Y., Light G.A., Braff D.L. Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology 2008, 199:331-388.
26. Swerdlow N.R., Lelham S.A., Sutherland Owens A.N., Chang W.L., Sassen S.D., Talledo J.A. Pramipexole effects on startle gating in rats and normal men. Psychopharmacology 2009, 205:689-698.
27. Weber M., Swerdlow N.R. Rat strain differences in startle gating-disruptive effects of apomorphine occur with both acoustic and visual prepulses. Pharmacol Biochem Behav 2008, 88:306-311.
28. Weber M., Chang W.L., Breier M., Ko D., Swerdlow N.R. Heritable strain differences in sensitivity to the startle gating-disruptive effects of D2 but not D3 receptor stimulation. Behav Pharmacol 2008, 19:786-795.
29. Weber M., Chang W.L., Durbin J.P., Park P.E., Luedtke R.R., Mach R.H., et al. Using prepulse inhibition to detect functional D3 receptor antagonism: effects of WC10 and WC44. Pharmacol Biochem Behav 2009, 93:141-147.
30. Yee B.K., Feldon J. Distinct forms of prepulse inhibition disruption distinguishable by the associated changes in prepulse-elicited reaction. Behav Brain Res 2009, 204:387-395.